...In a mouse model of melanoma, Scancell's SCIB1 ImmunoBody vaccine in combination with Homspera from ImmuneRegen BioSciences Inc....
...T lymphocyte (CTL) epitopes from tumor antigens over-expressed by cancer cells. In June, Scancell and ImmuneRegen...

...preclinical testing. ImmuneRegen will submit the proposal jointly with the University of Rochester (Rochester, N.Y.). ImmuneRegen...
...collaborating with the university's Center for Medical Countermeasures against Radiation to develop Homspera since 2009. ImmuneRegen BioSciences Inc....

...The companies will evaluate using Scancell's ImmunoBody vaccine technologies in combination with ImmuneRegen's preclinical candidate Homspera...
...helper cell and cytotoxic T lymphocyte (CTL) epitopes from tumor antigens over-expressed by cancer cells. ImmuneRegen BioSciences Inc....

...NeoStem will evaluate the effect of ImmuneRegen's Homspera on stem cell differentiation when combined with NeoStem's...
...a preclinical analog of the naturally occurring immunomodulator substance P. Financial terms were not disclosed. ImmuneRegen BioSciences Inc....

...start Phase I testing of Homspera plus a yet-to-be determined antigen and indication in 3Q10. ImmuneRegen BioSciences Inc....

...symptoms vs. untreated ferrets. Homspera is an analog of the naturally occurring immunomodulator substance P. ImmuneRegen BioSciences Inc....

...intent for CRO Azopharma to perform manufacturing, formulation development, preclinical toxicology and pharmacology studies of ImmuneRegen's...
...and for wound healing. Azopharma will receive yet to be determined ImmuneRegen shares and warrants. ImmuneRegen BioSciences Inc....

...associated with the infection. Homspera is an analog of the naturally occurring immunomodulator substance P. ImmuneRegen BioSciences Inc....

...ImmuneRegen acquired from the university full rights to a patent covering the active component of ImmuneRegen's...
...was originally co-owned by the parties. The university is eligible for undisclosed milestones and royalties. ImmuneRegen BioSciences Inc....